Timetable
Wednesday, September 4, 2019
|
||
| Hall A (CME Track) | ||
| 15:30 – 15:45 | Congress opening | |
| 15:45 – 17:30 | Plenary Session 1: Neoadjuvant therapy |
|
| 17:30 – 19:00 | Plenary Session 2: Controversies in trials: Designs, endpoints, etc. |
|
| 19:00 | Networking Reception | |
Thursday, September 5, 2019
|
||
| Hall A (CME Track) | Hall B (Non CME Track) | |
| 06:45 – 08:00 | Industry Breakfast Symposium | |
| 08:00 – 09:30 | Plenary Session 3: Genetics |
|
| 09:30 – 10:30 | Parallel Session 4: Endocrine therapy side effects |
Parallel Session 5: Imaging/Screening |
| 10:30 – 11:00 | Coffee break and poster viewing | |
| 11:00 – 12:30 | Parallel Session 6: Topics in HER2 positive breast cancer: Adjuvant/neoadjuvant |
Parallel Session 7: DCIS |
| 12:30 – 14:00 | Lunch Break and poster viewing | |
| 12:45 – 13:45 | Industry Lunch Symposium | |
| 14:00 – 15:30 | Plenary Session 8: Imaging in systemic disease |
|
| 15:30 – 16:00 | Coffee break and poster viewing | |
| 16:00 – 17:00 | Parallel Session 9: Issues in loco-regional management |
Parallel Session 10: Free papers |
| 17:00 – 18:00 | Poster session |
|
Friday, September 6, 2019
|
||
| Hall A (CME Track) | Hall B (Non CME Track) | |
| 06:45 – 08:00 | Industry Breakfast Symposium | |
| 08:00 – 09:30 | Parallel Session 11: Adjuvant endocrine therapy |
Parallel Session 12: Imaging as locoregional staging |
| 09:30 – 10:30 | Parallel Session 13: Triple negative breast cancer |
Parallel Session 14: Local therapy |
| 10:30 – 11:00 | Coffee break and poster viewing | |
| 11:00 – 12:30 | Plenary Session 15: Issues in advance disease |
|
| 12:30 – 13:45 | Lunch Break and Poster Viewing | |
| 12:45 – 13:45 | Industry Lunch Symposium | |
| 13:45 – 15:15 | Parallel Session 16 Reconstruction |
Parallel Session 17: Met HR+ve BC – CDK 4/6 inhibitors |
| 15:15 – 16:15 | Plenary Session 18: Vision for breast cancer 2025 |
|
| 16:15 – 16:30 | Congress closing and award presentation | |